WHY VLIFE?

The life science industry has been a late adopter of most innovative technologies, despite their large R&D budgets.

THE DATA PUZZLE

Each life science company generates terabytes of data and keeps it hidden behind a firewall. This is due partly to strict regulatory and compliance standards and partly to the extremely competitive environment in which these companies operate. Most of this information sits in silos, and for a long time, companies did not actually consider it suitable for retrospective analysis. With vLife, we are trying to address this problem.

WHAT IS VLIFE?

vLife LifeScience 4.0 is a data-driven platform to innovate and operationalize solutions faster.

VLIFE AT A GLANCE

728 million+

EMR/EHR records

of Medical Information Mart for Intensive Care (MIMIC) academic data

9,000+

IMAGES

from Digital Database for Screening Mammography

135 million+

CLAIMS RECORDS

of CMS SynPUF US gov research data

9 million+

MEDICAL DEVICE RECORDS

from U.S. Food & Drug Administration databases

19 million+

CLINICAL TRIAL RECORDS

of AACT database of Clinical Trials Transformation Initiatives (CTTI)

40+

IoT RECIPES

Hardware/electronics and software recipes

5 million+

HUMAN GENOME RECORDS

from National Center for Biotechnology Information database (NCBI)

4 million+

GOVERNMENT AGENCY RECORDS

from agglomerated databases

VLIFE OFFERINGS

DATA AS A SERVICE

Data APIs for the life science industry consist of academic and research data for EMR/EHR, claims, clinical trials, devices/sensors, and DNA banks.

ANALYTICS AS A SERVICE

Pre-bundled analytics package for care management, provider performance, health insights, and consumer engagement.

AI AS A SERVICE

Trained AI models allow you to explore AI solutions and experiment with your own data.

INNOVATION AS A SERVICE

Evolve and disrupt. We help you stand out and speed up your innovation by being disruptive.

IOT RECIPES

Conceptualization and rapid prototyping of IoT solutions with hardware/electronics and software recipes.

What People Are Saying About vLife

“Biopharma and Medtech companies require sensitive EMR data for pre-clinical research, clinical trials, biomarker analysis, pre-and post-market analysis to name a few use cases that warrant the need for prediction models trained on large datasets of practically unattainable data. To close these gaps, organizations and researchers require access to large repositories of high-quality health datasets for a range of secondary uses that have no clinical or medical implications, including software development, testing, and clinical training. Synthetic data will accelerate the pace of development for AI. vLife is our platform for synthetic and anonymous data for our customer who wish to find creative paths towards technology-based innovation to just stay relevant, let alone truly disrupt.”
– Jim Francis, Executive Vice President, Healthcare and Life Sciences, Virtusa


“Partnering with Virtusa will help the IBRI to achieve its objective of enabling regional, large life sciences companies to access data and technologies from a variety of organizations. Through the vLife™ open innovation platform, we’re exploring and enabling life sciences firms to accelerate progress towards finding next-level treatments by providing seamless access to focused, timeline-driven collaboration with universities, government entities, healthcare providers, and other research institutes and organizations.”
– Daniel H. Robertson, Ph.D, Research Fellow and Vice President of Digital Technology, and Director of the Applied Data Sciences Center for the IBRI


“Life science companies must address how to seize the upside of disruption in today’s transformation age. Future value in life science is driven by innovation that focuses on outcomes with a high degree of personalization and is fueled by unlocking the power of synthetic data.”
– Anthony Lange, Senior Vice President, Life Sciences, Virtusa


“By working together, we believe we can address the increasing customer demand for cloud transformation expertise in industry verticals such as financial services, healthcare, life sciences and more to create significant value for all parties in the process, Virtusa is a valued member of the AWS Partner Network (APN) and the SCA deepens the relationship between our two organizations to provide more value to our customers.”
– Terry Wise, Global Vice President of Channels and Alliances, Amazon Web Services, Inc.


“Data drives solutions to the most difficult healthcare challenges of today and tomorrow. Researchers need data that is accessible, complete, and accurate. We need to look at synthetic data differently by applying AI and Big Data technologies to extend and enhance real-world evidence. We’re excited to see how Proxi will accelerate healthcare analysis and outcomes”
– Jeff Graham, Principal Engineer of Data Analytics at Fuse


“As a firm, our roots and ethos are deep in software engineering. Our program with IBRI is only one example of how we are working with clients to solve complex industry issues. We have also solved similar issues for companies in other industries, such as banking, insurance, media, communication, info services, healthcare, and life sciences.”
– Samir Dhir, President at Virtusa

    Virtusa may email you to keep you up-to-date with our innovative technology solutions. You can change your preferences at any time. If you do not wish to receive these emails please tick the box to opt out.
  • This field is for validation purposes and should be left unchanged.
Have a question about vLife?